A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved ...

Most people who get thyroid cancer get it through acquired gene mutation. This means the gene mutation happened randomly in their lifetime. For instance, half of all papillary thyroid cancers are ...

Additionally, targeted therapies have been developed to address specific genetic mutations associated with thyroid cancer, offering hope for patients with previously difficult-to-treat variants.

We identified a germline mutation in the DUOX2 gene ... These findings provide valuable insights into the genetic landscape of thyroid cancer in Indian patients and offer potential avenues for ...

Thyroid cancer occurs when thyroid cells—which make up the butterfly-shaped gland that sits below your voice box—acquire genetic mutations that lead to an uncontrolled growth, says Dr. Zanocco.

A pre-surgical combination therapy including pembrolizumab plus dabrafenib and trametinib (DTP) significantly improved ...

From hormone-disrupting chemicals to chronic stress and genetics, understanding thyroid health is key to preventing ...

This post-hoc analysis used a combined cohort of 509 patients with RET-mutated advanced or metastatic medullary thyroid cancer who had received selpercatinib in the two trials. Hadoux reported ...

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS ...